Home
Conditions
Multiple Myeloma

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

2,608 public trials 494 recruiting studies

Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Completed

A Study of Daratumumab in Japanese Participants With Relapsed or Refractory Multiple Myeloma

NCT02116569

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations: Nagoya, Japan

Tokyo, Japan

View Trial Details

Completed

UARK 89-001 Phase II Study of Intensive "TOTAL THERAPY" For Untreated or Minimally Treated Patients With Multiple Myeloma

NCT00580372

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: University of Arkansas for Medical Sciences/MIRT Little Rock, Arkansas, United States

View Trial Details

Completed

Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry on a Cohort of Patients Receiving Plerixafor

NCT01362972

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

Bendamustine, Lenalidomide (Revlimid®) and Dexamethasone (BRd) as 2nd-line Therapy for Patients With Relapsed or Refractory Multiple Myeloma

NCT01701076

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Kantonsspital St. Gallen Sankt Gallen, Switzerland

View Trial Details

Completed

Efficacy Study of ZD6474 to Treat Multiple Myeloma Cancer

NCT00047788

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Research Site New York, United States

Research Site Edmonton, Alberta, Canada

Research Site Halifax, Nova Scotia, Canada

Research Site Hamilton, Ontario, Canada

View Trial Details

Completed

Biomarkers Related to Thrombosis in Patients With Newly Diagnosed Multiple Myeloma Receiving Chemotherapy

NCT01132833

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Embolism and Thrombosis, +15 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Completed

Umbilical Cord Blood Transplant for Hematological Malignancies

NCT00891592

Conditions: ALL, AML, Blood Protein Disorders, +21 more
Locations: University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Continuous Versus Intermittent Dosing Regimens for Pomalidomide in Relapsed/Refractory Multiple Myeloma

NCT01319422

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Yale University New Haven, Connecticut, United States

View Trial Details

Completed

Melphalan and Autologous Stem Cell Transplant Followed By Bortezomib and Dexamethasone in Treating Patients With Previously Untreated Systemic Amyloidosis

NCT00458822

Conditions: Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +18 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Economic Evaluation of the Use of Plerixafor for Autologous HSC Transplantation for Multiple Myeloma

NCT02861287

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Institut Paoli-Calmettes Marseille, Bouches-du Rhône, France

View Trial Details

Multiple Myeloma

Multiple Myeloma trial results

Related conditions